TLDR Many survivors of critical illness, especially those with sepsis, experience hair loss.
In a study from 2019 involving 123 survivors of critical illness from ten hospitals in Wales, 36% reported experiencing alopecia after an ICU stay of 5 days or more. The study identified sepsis/septic shock as the only significant risk factor for alopecia, with an odds ratio of 5.1. No significant differences were found in serum lactate levels or APACHE II illness severity scores between those with and without alopecia. The findings suggest the need for further research into the causes of alopecia following critical illness and sepsis, and for healthcare providers to better communicate the risk of hair loss to patients and their families. Despite limitations such as not meeting the target sample size and potential reporting bias, the study highlights alopecia as a common concern for ICU survivors, especially those who had sepsis or septic shock.
10 citations,
January 2015 in “Journal of Dermatology and Dermatologic Surgery” Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.
5 citations,
July 2003 in “Pediatric Critical Care Medicine” Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.
58 citations,
October 2001 in “Dermatologic Clinics” Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.
147 citations,
April 1994 in “Drug Safety” Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.
21 citations,
January 1988 in “Critical Care Medicine” Critically ill patients may experience temporary hair loss after a fever.
4 citations,
June 2022 in “BioMed Research International” Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.
17 citations,
August 2019 in “Archives of Cardiovascular Diseases” Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.
3 citations,
July 2017 in “Elsevier eBooks” Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.
3 citations,
June 2018 in “Internal Medicine” Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.
